Claudia Nerlich

Title: Claudia Nerlich: Innovator in Blood Clotting Factor Research

Introduction

Claudia Nerlich is a prominent inventor based in Marburg, Germany. She has made significant contributions to the field of blood clotting research, particularly through her innovative patents. With a total of 5 patents, her work has advanced the understanding of coagulation factors and their implications in medical diagnostics.

Latest Patents

Nerlich's latest patents include groundbreaking research on mutants of the factor VII-activating protease (FSAP) and detection methods using specific antibodies. One of her notable patents describes mutants of the DNA sequence coding for FSAP, which activates blood clotting factor VII. These mutants include specific base exchanges at nucleotide positions 1177 and 1601, leading to significant amino acid exchanges that affect the protease's function. Additionally, she has developed diagnostic methods for detecting FSAP in body fluids and tissue cells, which are crucial for identifying patients with genetic variations in FSAP expression. Another patent focuses on the Marburg I mutant of FSAP as a risk factor for arterial thrombosis, detailing methods for detecting these mutants that are identified as risk factors.

Career Highlights

Throughout her career, Claudia Nerlich has worked with notable companies such as CSL Behring GmbH and Aventis Behring GmbH. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to significant advancements in medical research.

Collaborations

Some of her coworkers include Juergen Roemisch and Thomas Weimer, who have collaborated with her on various projects related to her patents and research.

Conclusion

Claudia Nerlich's contributions to the field of blood clotting research through her patents and collaborations highlight her role as an influential inventor. Her work continues to impact medical diagnostics and treatment options for patients with coagulation disorders.